Activist 13D/13G Filings - eFFECTOR Therapeutics Inc. (EFTR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
3:48 pm
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
PFIZER INC
PFE
2,243,850
3.47%
2,243,850increase
(New Position)
View
2024-02-14
09:48 am
Unchanged
13GEFFECTOR THERAPEUTICS INC
EFTR
SECTORAL ASSET MANAGEMENT INC2,382,644
3.7%
0
(Unchanged)
View
2024-02-09
8:14 pm
Sale
13GEFFECTOR THERAPEUTICS INC
EFTR
SR ONE CAPITAL MANAGEMENT LLC0
0%
-6,822,114decrease
(Position Closed)
View
2024-02-05
4:15 pm
Unchanged
13GEFFECTOR THERAPEUTICS INC
EFTR
Altitude Life Science Ventures Fund II L.P.2,826,350
4.4%
0
(Unchanged)
View
2023-11-22
4:16 pm
Sale
13DEFFECTOR THERAPEUTICS INC
EFTR
COLUMN GROUP II LP0
0%
-4,091,734decrease
(Position Closed)
View
2023-09-15
4:05 pm
Sale
13DEFFECTOR THERAPEUTICS INC
EFTR
COLUMN GROUP II LP4,091,734
6.6%
-217,595decrease
(-5.05%)
View
2023-08-18
4:16 pm
Unchanged
13DEFFECTOR THERAPEUTICS INC
EFTR
Carlyle Group Inc.
CG
4,829,891
7.8%
0
(Unchanged)
View
2023-03-07
5:25 pm
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
Altitude Life Science Ventures Fund II L.P.2,826,350
6.7%
2,826,350increase
(New Position)
View
2023-02-14
06:33 am
Unchanged
13GEFFECTOR THERAPEUTICS INC
EFTR
Empyrean Capital Partners LP0
0%
0
(Unchanged)
View
2023-02-13
3:06 pm
Sale
13GEFFECTOR THERAPEUTICS INC
EFTR
SECTORAL ASSET MANAGEMENT INC2,382,644
5.7%
-100decrease
(-0.00%)
View
2022-08-18
8:04 pm
Purchase
13DEFFECTOR THERAPEUTICS INC
EFTR
US VENTURE PARTNERS X LP4,480,578
10.8%
4,480,578increase
(New Position)
View
2022-08-18
7:54 pm
Sale
13DEFFECTOR THERAPEUTICS INC
EFTR
US VENTURE PARTNERS X LP0
0%
-4,822,114decrease
(Position Closed)
View
2022-08-11
4:55 pm
Purchase
13DEFFECTOR THERAPEUTICS INC
EFTR
Carlyle Group Inc.
CG
4,829,891
11.7%
4,829,891increase
(New Position)
View
2022-02-14
4:04 pm
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
PFIZER INC
PFE
2,243,850
5.56%
2,243,850increase
(New Position)
View
2022-02-11
8:35 pm
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
SR ONE CAPITAL MANAGEMENT LLC6,822,114
16.9%
6,822,114increase
(New Position)
View
2022-02-11
6:32 pm
Unchanged
13GEFFECTOR THERAPEUTICS INC
EFTR
Beryl Capital Management LLC0
0%
0
(Unchanged)
View
2022-02-11
09:18 am
Purchase
13GEFFECTOR THERAPEUTICS INC
EFTR
SECTORAL ASSET MANAGEMENT INC2,382,744
5.9%
2,382,744increase
(New Position)
View
2022-01-31
4:16 pm
Unchanged
13GEFFECTOR THERAPEUTICS INC
EFTR
Linden Capital L.P.0
0%
0
(Unchanged)
View
2021-09-13
06:23 am
Purchase
13DEFFECTOR THERAPEUTICS INC
EFTR
US VENTURE PARTNERS X LP4,822,114
11.9%
4,822,114increase
(New Position)
View
2021-09-07
5:12 pm
Purchase
13DEFFECTOR THERAPEUTICS INC
EFTR
COLUMN GROUP II LP4,309,329
10.6%
4,309,329increase
(New Position)
View
Goto 0, 1, Next